论文部分内容阅读
8月8日上午,“齐二药”假药案5名涉案人员,在广州市中级人民法院出庭受审。去年4月,广州中山大学附属三院65名陆续使用齐齐哈尔第二制药有限公司生产的亮菌甲素注射液的患者,部分出现了肾衰竭等严重症状,其中13名患者最终死亡。5月,此药被认定为假药,全国紧急查封。带强烈毒性的二甘醇如何冲过重重貌似严密的质量审查关卡,假冒丙二醇生产出致命假药?涉嫌“重大责任事故罪”的原齐二药公司采购员钮忠仁、化验室主任陈桂芬,主管采购的副总经理郭兴平、主管生产技术的副总经理朱传华以及总经理尹家德,按顺序依次站在了法庭被告席上。在一天的庭审中,5名被告人逐一供述,完整地串起了一个荒唐制假的链条。
On the morning of August 8, 5 people involved in the “Qi Er Yao” fake drug case went to trial in Guangzhou Intermediate People’s Court. In April last year, 65 third hospitals affiliated to Sun Yat-sen University in Guangzhou used some of the serious symptoms of renal failure, including 65 cases of strychnine-producing injection produced by Qiqihaer Second Pharmaceutical Co., Ltd., of which 13 patients eventually died. May, the drug was identified as fake drugs, the national emergency seizure. With a strong toxicity of diethylene glycol how to rush through a number of seemingly strict quality control checkpoints, counterfeit propylene glycol to produce deadly counterfeit drugs suspected of “serious accidental accident” Qi original Qi Er pharmaceutical company Purchasing Officer, Laboratory Director Chen Guifen Guo Xingping, the deputy general manager in charge of purchasing, Zhu Chuanhua, the deputy general manager in charge of production technology, and Yin Jiade, the general manager, were in turn standing in the dock of the court. During the one-day trial, the five accused one by one confession, a complete string of absurd false chain.